agilon health Plunges On A Poor Prognosis (Rating Downgrade)
Portfolio Pulse from
agilon health, inc. has been downgraded from 'hold' to 'sell' due to disappointing Q3 results, reduced guidance, and a significant stock price drop. Rising medical costs and expansion expenses have severely impacted profitability, leading to increased net loss and negative EBITDA.
November 09, 2024 | 12:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
agilon health, inc. has been downgraded to 'sell' due to poor Q3 results and reduced guidance. The stock has dropped 60.1% as rising medical costs and expansion expenses impact profitability.
The downgrade to 'sell' reflects the company's poor financial performance in Q3, with a significant stock price drop of 60.1%. Rising medical costs and expansion expenses have led to increased net loss and negative EBITDA, impacting investor confidence.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100